Results 161 to 170 of about 38,106 (211)

Toshiba: EMEA voll im Griff

Call Center Profi, 2010
Open Source-Software ist nur etwas fur kleine Betriebe. Diese Behauptung ist genauso falsch wie die, dass bei Open Source alles kostenlos ist. Wie es bei Toshiba Europe gelang, eine Open Source-basierte Losung in den elf Call Centern der EMEA-Region zu integrieren, lesen Sie hier.
openaire   +1 more source

Emea rubra Leidy 1850

22. rubra Leidy, 1850 Source. In the binomen Emea rubra by Leidy (1850: 125). Type locality. Philadelphia, USA (Fig. 9). Etymology. Latin adjective, ruber, rubra, rubrum, meaning “red”. Remarks. Leidy’s (1850: 125) original description of the ‘alimentary canal’—“intestine cylindrical, narrowed posteriorly, furnished with a small, round, muscular ...
openaire   +1 more source

European Medicines Evaluation Agency (EMEA)

2009
Registration authority within the EC and coordinating centre for the centralised procedure, renamed to European Medicines Agency, sited in London; → see also expert detache.
openaire   +1 more source

Emea

World Literature Today, 1987
Gorka Aulestia, Xabier Amuriza
openaire   +1 more source

FDA and EMEA pool scientific advice

Nature Biotechnology, 2004
Biotech companies could have their say in setting up standards for regulatory approval of cutting edge drugs, as they benefit from parallel scientific advice from Europe and the US.
openaire   +1 more source

Emea sillimani Girard 1893

Published as part of Kajihara, Hiroshi, 2025, A taxonomic revision of the freshwater monostiliferous hoplonemertean genus Prostoma Dugès, 1828 (Nemertea: Eumonostilifera): a radical solution or an over-lumping?, pp.
openaire   +1 more source

Low–energy–consuming CO2 capture by liquid–liquid biphasic absorbents of EMEA/DEEA/PX

Chemical Engineering Journal, 2022
Qizheng Zhao, Siming Chen
exaly  

6th EMEA-IFAPP Conference

International Journal of Pharmaceutical Medicine, 2002
openaire   +2 more sources

Farmaci EMEA ed innovazione terapeutica

2006
L’innovazione in farmacoterapia è tema molto attuale e fonte di numerosi dibattiti per quanti, a vario titolo, s’interessano di farmaci: agenzie regolatorie, aziende produttrici, operatori sanitari, ricercatori, pazienti e cittadini. In particolare, le agenzie regolatorie e i “policy-makers”, essendo chiamati a decidere come meglio allocare le risorse
MOTOLA, DOMENICO, DE PONTI, FABRIZIO, MONTANARO, NICOLA   +2 more
openaire   +1 more source

Can ERM ratings explain the performance and risk of EMEA insurance companies?

Journal of Risk Research, 2022
Irma Chacón, Pablo Durán-Santomil
exaly